Wockhardt soars as Zaynich shows promise against superbugs

Wockhardt soared 13.64% to Rs 780 after the company's experimental antibiotic, Zaynich, successfully treated a US cancer patient with a chronic thigh infection caused by extremely resistant bacteria.